We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Receptor Blueprint Helps Design Osteoporosis Drugs

News   Nov 20, 2018 | Original story from University of Zurich

 
Receptor Blueprint Helps Design Osteoporosis Drugs

The receptor is the key regulatory switch controlling calcium release from bones, and thus a prime target for developing new drugs for the treatment of osteoporosis. The receptor consists of an extracellular part (purple) and a part that resides in the membrane (green). Parathyroid hormone (orange) activates the receptor. Credit: University of Zurich

 
 
Advertisement
 

RELATED ARTICLES

New Class of Cancer Fighting Compounds Discovered

News

A new class of anti-cancer compounds that effectively kill liver and breast cancer cells has been discovered by scientists.

READ MORE

Dual Vaccination Prevents Allergic Asthma in New Mouse Study

News

Promising results in a mouse model could point the way to the development of a therapy to treat half of all asthma cases.

READ MORE

MDMA-Assisted Therapy Effective at Treating PTSD, Finds Breakthrough Trial

News

A breakthrough trial suggests that MDMA-assisted therapy is both safe and effective for people with post-traumatic stress disorder (PTSD).

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE